The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-smal...
The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Non-small cell lung cancer (NSCLC) remains a dire disease being the first cause of cancer death among both genders. Early-stage NSCLC often has better treatment outcomes despite it being a highly heterogeneous disease. So far, the neo-adjuvant chemotherapy strategies have led to a small benefit with an improvement of 5% in overall survival as an ab...
Alternative Titles
Full title
The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_14d7dbfbb73e41749718250deeb45c0f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_14d7dbfbb73e41749718250deeb45c0f
Other Identifiers
ISSN
2730-6011
E-ISSN
2730-6011
DOI
10.1007/s12672-025-01826-7
